nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP3A5—Ifosfamide—testicular cancer	0.192	0.343	CbGbCtD
Granisetron—CYP3A5—Etoposide—testicular cancer	0.092	0.164	CbGbCtD
Granisetron—CYP3A4—Ifosfamide—testicular cancer	0.075	0.134	CbGbCtD
Granisetron—CYP2D6—Vinblastine—testicular cancer	0.0626	0.112	CbGbCtD
Granisetron—CYP3A4—Vinblastine—testicular cancer	0.0398	0.071	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—testicular cancer	0.0385	0.0686	CbGbCtD
Granisetron—CYP3A4—Etoposide—testicular cancer	0.0359	0.064	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—testicular cancer	0.0245	0.0436	CbGbCtD
Granisetron—Hypotension—Etoposide—testicular cancer	0.000658	0.0015	CcSEcCtD
Granisetron—Rash—Bleomycin—testicular cancer	0.000657	0.0015	CcSEcCtD
Granisetron—Pain—Cisplatin—testicular cancer	0.000657	0.0015	CcSEcCtD
Granisetron—Dermatitis—Bleomycin—testicular cancer	0.000657	0.00149	CcSEcCtD
Granisetron—Hypersensitivity—Ifosfamide—testicular cancer	0.000656	0.00149	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000655	0.00149	CcSEcCtD
Granisetron—Dysuria—Epirubicin—testicular cancer	0.000649	0.00148	CcSEcCtD
Granisetron—Abdominal distension—Doxorubicin—testicular cancer	0.000646	0.00147	CcSEcCtD
Granisetron—Asthenia—Ifosfamide—testicular cancer	0.000639	0.00145	CcSEcCtD
Granisetron—Eosinophilia—Doxorubicin—testicular cancer	0.000636	0.00145	CcSEcCtD
Granisetron—Sweating—Methotrexate—testicular cancer	0.000634	0.00144	CcSEcCtD
Granisetron—Photosensitivity reaction—Epirubicin—testicular cancer	0.000633	0.00144	CcSEcCtD
Granisetron—Feeling abnormal—Cisplatin—testicular cancer	0.000633	0.00144	CcSEcCtD
Granisetron—Paraesthesia—Etoposide—testicular cancer	0.000632	0.00144	CcSEcCtD
Granisetron—Pruritus—Ifosfamide—testicular cancer	0.00063	0.00143	CcSEcCtD
Granisetron—Dyspnoea—Etoposide—testicular cancer	0.000627	0.00143	CcSEcCtD
Granisetron—Somnolence—Etoposide—testicular cancer	0.000626	0.00142	CcSEcCtD
Granisetron—Angina pectoris—Doxorubicin—testicular cancer	0.000625	0.00142	CcSEcCtD
Granisetron—Hepatobiliary disease—Methotrexate—testicular cancer	0.000625	0.00142	CcSEcCtD
Granisetron—Epistaxis—Methotrexate—testicular cancer	0.000623	0.00142	CcSEcCtD
Granisetron—Nausea—Bleomycin—testicular cancer	0.000619	0.00141	CcSEcCtD
Granisetron—Vomiting—Dactinomycin—testicular cancer	0.000618	0.00141	CcSEcCtD
Granisetron—Rash—Dactinomycin—testicular cancer	0.000613	0.0014	CcSEcCtD
Granisetron—Decreased appetite—Etoposide—testicular cancer	0.000612	0.00139	CcSEcCtD
Granisetron—Diarrhoea—Ifosfamide—testicular cancer	0.00061	0.00139	CcSEcCtD
Granisetron—Gastrointestinal disorder—Etoposide—testicular cancer	0.000608	0.00138	CcSEcCtD
Granisetron—Body temperature increased—Cisplatin—testicular cancer	0.000607	0.00138	CcSEcCtD
Granisetron—Jaundice—Epirubicin—testicular cancer	0.000603	0.00137	CcSEcCtD
Granisetron—Pain—Etoposide—testicular cancer	0.000602	0.00137	CcSEcCtD
Granisetron—Constipation—Etoposide—testicular cancer	0.000602	0.00137	CcSEcCtD
Granisetron—Urinary tract infection—Epirubicin—testicular cancer	0.000601	0.00137	CcSEcCtD
Granisetron—Dysuria—Doxorubicin—testicular cancer	0.0006	0.00137	CcSEcCtD
Granisetron—Sweating—Epirubicin—testicular cancer	0.000593	0.00135	CcSEcCtD
Granisetron—Dizziness—Ifosfamide—testicular cancer	0.000589	0.00134	CcSEcCtD
Granisetron—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000586	0.00133	CcSEcCtD
Granisetron—Hepatobiliary disease—Epirubicin—testicular cancer	0.000585	0.00133	CcSEcCtD
Granisetron—Epistaxis—Epirubicin—testicular cancer	0.000583	0.00133	CcSEcCtD
Granisetron—Sinusitis—Epirubicin—testicular cancer	0.00058	0.00132	CcSEcCtD
Granisetron—Feeling abnormal—Etoposide—testicular cancer	0.00058	0.00132	CcSEcCtD
Granisetron—Nausea—Dactinomycin—testicular cancer	0.000578	0.00131	CcSEcCtD
Granisetron—Gastrointestinal pain—Etoposide—testicular cancer	0.000575	0.00131	CcSEcCtD
Granisetron—Visual impairment—Methotrexate—testicular cancer	0.000572	0.0013	CcSEcCtD
Granisetron—Vomiting—Ifosfamide—testicular cancer	0.000567	0.00129	CcSEcCtD
Granisetron—Hypersensitivity—Cisplatin—testicular cancer	0.000566	0.00129	CcSEcCtD
Granisetron—Bradycardia—Epirubicin—testicular cancer	0.000565	0.00129	CcSEcCtD
Granisetron—Rash—Ifosfamide—testicular cancer	0.000562	0.00128	CcSEcCtD
Granisetron—Dermatitis—Ifosfamide—testicular cancer	0.000561	0.00128	CcSEcCtD
Granisetron—Urticaria—Etoposide—testicular cancer	0.000559	0.00127	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—testicular cancer	0.000558	0.00127	CcSEcCtD
Granisetron—Rhinitis—Epirubicin—testicular cancer	0.000557	0.00127	CcSEcCtD
Granisetron—Abdominal pain—Etoposide—testicular cancer	0.000556	0.00127	CcSEcCtD
Granisetron—Body temperature increased—Etoposide—testicular cancer	0.000556	0.00127	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—testicular cancer	0.000556	0.00127	CcSEcCtD
Granisetron—Asthenia—Cisplatin—testicular cancer	0.000551	0.00125	CcSEcCtD
Granisetron—Sweating—Doxorubicin—testicular cancer	0.000549	0.00125	CcSEcCtD
Granisetron—Connective tissue disorder—Epirubicin—testicular cancer	0.000546	0.00124	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000541	0.00123	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—testicular cancer	0.00054	0.00123	CcSEcCtD
Granisetron—Angiopathy—Methotrexate—testicular cancer	0.000538	0.00123	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—testicular cancer	0.000537	0.00122	CcSEcCtD
Granisetron—Visual impairment—Epirubicin—testicular cancer	0.000535	0.00122	CcSEcCtD
Granisetron—Chills—Methotrexate—testicular cancer	0.000532	0.00121	CcSEcCtD
Granisetron—Nausea—Ifosfamide—testicular cancer	0.000529	0.0012	CcSEcCtD
Granisetron—Diarrhoea—Cisplatin—testicular cancer	0.000526	0.0012	CcSEcCtD
Granisetron—Alopecia—Methotrexate—testicular cancer	0.000524	0.00119	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—testicular cancer	0.000523	0.00119	CcSEcCtD
Granisetron—Hypersensitivity—Etoposide—testicular cancer	0.000518	0.00118	CcSEcCtD
Granisetron—Malnutrition—Methotrexate—testicular cancer	0.000517	0.00118	CcSEcCtD
Granisetron—Flushing—Epirubicin—testicular cancer	0.000515	0.00117	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—testicular cancer	0.000515	0.00117	CcSEcCtD
Granisetron—Dysgeusia—Methotrexate—testicular cancer	0.000506	0.00115	CcSEcCtD
Granisetron—Asthenia—Etoposide—testicular cancer	0.000505	0.00115	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—testicular cancer	0.000505	0.00115	CcSEcCtD
Granisetron—Angiopathy—Epirubicin—testicular cancer	0.000504	0.00115	CcSEcCtD
Granisetron—Chills—Epirubicin—testicular cancer	0.000498	0.00113	CcSEcCtD
Granisetron—Pruritus—Etoposide—testicular cancer	0.000498	0.00113	CcSEcCtD
Granisetron—Arrhythmia—Epirubicin—testicular cancer	0.000496	0.00113	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—testicular cancer	0.000495	0.00113	CcSEcCtD
Granisetron—Alopecia—Epirubicin—testicular cancer	0.000491	0.00112	CcSEcCtD
Granisetron—Vomiting—Cisplatin—testicular cancer	0.000488	0.00111	CcSEcCtD
Granisetron—Rash—Cisplatin—testicular cancer	0.000484	0.0011	CcSEcCtD
Granisetron—Dermatitis—Cisplatin—testicular cancer	0.000484	0.0011	CcSEcCtD
Granisetron—Malnutrition—Epirubicin—testicular cancer	0.000483	0.0011	CcSEcCtD
Granisetron—Diarrhoea—Etoposide—testicular cancer	0.000482	0.0011	CcSEcCtD
Granisetron—Ill-defined disorder—Methotrexate—testicular cancer	0.000479	0.00109	CcSEcCtD
Granisetron—Anaemia—Methotrexate—testicular cancer	0.000477	0.00109	CcSEcCtD
Granisetron—Flushing—Doxorubicin—testicular cancer	0.000477	0.00109	CcSEcCtD
Granisetron—Flatulence—Epirubicin—testicular cancer	0.000476	0.00108	CcSEcCtD
Granisetron—Tension—Epirubicin—testicular cancer	0.000474	0.00108	CcSEcCtD
Granisetron—Dysgeusia—Epirubicin—testicular cancer	0.000473	0.00108	CcSEcCtD
Granisetron—Nervousness—Epirubicin—testicular cancer	0.000469	0.00107	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—testicular cancer	0.000466	0.00106	CcSEcCtD
Granisetron—Malaise—Methotrexate—testicular cancer	0.000466	0.00106	CcSEcCtD
Granisetron—Dizziness—Etoposide—testicular cancer	0.000465	0.00106	CcSEcCtD
Granisetron—Vertigo—Methotrexate—testicular cancer	0.000464	0.00106	CcSEcCtD
Granisetron—Leukopenia—Methotrexate—testicular cancer	0.000462	0.00105	CcSEcCtD
Granisetron—Chills—Doxorubicin—testicular cancer	0.000461	0.00105	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—testicular cancer	0.000459	0.00104	CcSEcCtD
Granisetron—Nausea—Cisplatin—testicular cancer	0.000456	0.00104	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—testicular cancer	0.000454	0.00103	CcSEcCtD
Granisetron—Cough—Methotrexate—testicular cancer	0.000451	0.00103	CcSEcCtD
Granisetron—Ill-defined disorder—Epirubicin—testicular cancer	0.000448	0.00102	CcSEcCtD
Granisetron—Vomiting—Etoposide—testicular cancer	0.000447	0.00102	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—testicular cancer	0.000447	0.00102	CcSEcCtD
Granisetron—Anaemia—Epirubicin—testicular cancer	0.000447	0.00102	CcSEcCtD
Granisetron—Agitation—Epirubicin—testicular cancer	0.000444	0.00101	CcSEcCtD
Granisetron—Rash—Etoposide—testicular cancer	0.000444	0.00101	CcSEcCtD
Granisetron—Dermatitis—Etoposide—testicular cancer	0.000443	0.00101	CcSEcCtD
Granisetron—Headache—Etoposide—testicular cancer	0.000441	0.001	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—testicular cancer	0.000441	0.001	CcSEcCtD
Granisetron—Arthralgia—Methotrexate—testicular cancer	0.00044	0.001	CcSEcCtD
Granisetron—Chest pain—Methotrexate—testicular cancer	0.00044	0.001	CcSEcCtD
Granisetron—Tension—Doxorubicin—testicular cancer	0.000439	0.000999	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—testicular cancer	0.000438	0.000997	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000437	0.000994	CcSEcCtD
Granisetron—Malaise—Epirubicin—testicular cancer	0.000436	0.000992	CcSEcCtD
Granisetron—Discomfort—Methotrexate—testicular cancer	0.000434	0.000989	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—testicular cancer	0.000434	0.000989	CcSEcCtD
Granisetron—Vertigo—Epirubicin—testicular cancer	0.000434	0.000988	CcSEcCtD
Granisetron—Syncope—Epirubicin—testicular cancer	0.000433	0.000987	CcSEcCtD
Granisetron—Leukopenia—Epirubicin—testicular cancer	0.000433	0.000985	CcSEcCtD
Granisetron—Palpitations—Epirubicin—testicular cancer	0.000427	0.000972	CcSEcCtD
Granisetron—Loss of consciousness—Epirubicin—testicular cancer	0.000425	0.000967	CcSEcCtD
Granisetron—Cough—Epirubicin—testicular cancer	0.000422	0.00096	CcSEcCtD
Granisetron—Anaphylactic shock—Methotrexate—testicular cancer	0.000422	0.000959	CcSEcCtD
Granisetron—Infection—Methotrexate—testicular cancer	0.000419	0.000953	CcSEcCtD
Granisetron—Nausea—Etoposide—testicular cancer	0.000418	0.000951	CcSEcCtD
Granisetron—Hypertension—Epirubicin—testicular cancer	0.000417	0.00095	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—testicular cancer	0.000415	0.000944	CcSEcCtD
Granisetron—Nervous system disorder—Methotrexate—testicular cancer	0.000413	0.000941	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—testicular cancer	0.000413	0.000941	CcSEcCtD
Granisetron—Thrombocytopenia—Methotrexate—testicular cancer	0.000413	0.000939	CcSEcCtD
Granisetron—Arthralgia—Epirubicin—testicular cancer	0.000412	0.000937	CcSEcCtD
Granisetron—Chest pain—Epirubicin—testicular cancer	0.000412	0.000937	CcSEcCtD
Granisetron—Agitation—Doxorubicin—testicular cancer	0.000411	0.000935	CcSEcCtD
Granisetron—Anxiety—Epirubicin—testicular cancer	0.00041	0.000933	CcSEcCtD
Granisetron—Skin disorder—Methotrexate—testicular cancer	0.000409	0.000932	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000409	0.00093	CcSEcCtD
Granisetron—Hyperhidrosis—Methotrexate—testicular cancer	0.000408	0.000927	CcSEcCtD
Granisetron—Discomfort—Epirubicin—testicular cancer	0.000407	0.000925	CcSEcCtD
Granisetron—Malaise—Doxorubicin—testicular cancer	0.000403	0.000918	CcSEcCtD
Granisetron—Dry mouth—Epirubicin—testicular cancer	0.000402	0.000916	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—testicular cancer	0.000402	0.000915	CcSEcCtD
Granisetron—Syncope—Doxorubicin—testicular cancer	0.000401	0.000913	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—testicular cancer	0.0004	0.000911	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—testicular cancer	0.000395	0.0009	CcSEcCtD
Granisetron—Anaphylactic shock—Epirubicin—testicular cancer	0.000394	0.000898	CcSEcCtD
Granisetron—Oedema—Epirubicin—testicular cancer	0.000394	0.000898	CcSEcCtD
Granisetron—Hypotension—Methotrexate—testicular cancer	0.000394	0.000896	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—testicular cancer	0.000393	0.000895	CcSEcCtD
Granisetron—Infection—Epirubicin—testicular cancer	0.000392	0.000892	CcSEcCtD
Granisetron—Cough—Doxorubicin—testicular cancer	0.00039	0.000888	CcSEcCtD
Granisetron—Shock—Epirubicin—testicular cancer	0.000388	0.000883	CcSEcCtD
Granisetron—Nervous system disorder—Epirubicin—testicular cancer	0.000387	0.00088	CcSEcCtD
Granisetron—Thrombocytopenia—Epirubicin—testicular cancer	0.000386	0.000879	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—testicular cancer	0.000386	0.000879	CcSEcCtD
Granisetron—Tachycardia—Epirubicin—testicular cancer	0.000385	0.000876	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000384	0.000874	CcSEcCtD
Granisetron—Skin disorder—Epirubicin—testicular cancer	0.000383	0.000872	CcSEcCtD
Granisetron—Hyperhidrosis—Epirubicin—testicular cancer	0.000381	0.000868	CcSEcCtD
Granisetron—Insomnia—Methotrexate—testicular cancer	0.000381	0.000868	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—testicular cancer	0.000381	0.000867	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—testicular cancer	0.000381	0.000867	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—testicular cancer	0.000379	0.000864	CcSEcCtD
Granisetron—Paraesthesia—Methotrexate—testicular cancer	0.000379	0.000861	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000378	0.000861	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—testicular cancer	0.000376	0.000856	CcSEcCtD
Granisetron—Dyspnoea—Methotrexate—testicular cancer	0.000376	0.000855	CcSEcCtD
Granisetron—Somnolence—Methotrexate—testicular cancer	0.000375	0.000853	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—testicular cancer	0.000372	0.000848	CcSEcCtD
Granisetron—Dyspepsia—Methotrexate—testicular cancer	0.000371	0.000844	CcSEcCtD
Granisetron—Hypotension—Epirubicin—testicular cancer	0.000369	0.000839	CcSEcCtD
Granisetron—Decreased appetite—Methotrexate—testicular cancer	0.000366	0.000834	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—testicular cancer	0.000365	0.000831	CcSEcCtD
Granisetron—Oedema—Doxorubicin—testicular cancer	0.000365	0.000831	CcSEcCtD
Granisetron—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000364	0.000828	CcSEcCtD
Granisetron—Infection—Doxorubicin—testicular cancer	0.000363	0.000825	CcSEcCtD
Granisetron—Pain—Methotrexate—testicular cancer	0.00036	0.00082	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000359	0.000818	CcSEcCtD
Granisetron—Shock—Doxorubicin—testicular cancer	0.000359	0.000817	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—testicular cancer	0.000358	0.000815	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—testicular cancer	0.000357	0.000813	CcSEcCtD
Granisetron—Insomnia—Epirubicin—testicular cancer	0.000357	0.000812	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—testicular cancer	0.000356	0.000811	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—testicular cancer	0.000355	0.000807	CcSEcCtD
Granisetron—Paraesthesia—Epirubicin—testicular cancer	0.000354	0.000806	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—testicular cancer	0.000353	0.000803	CcSEcCtD
Granisetron—Dyspnoea—Epirubicin—testicular cancer	0.000352	0.0008	CcSEcCtD
Granisetron—Somnolence—Epirubicin—testicular cancer	0.000351	0.000798	CcSEcCtD
Granisetron—Feeling abnormal—Methotrexate—testicular cancer	0.000347	0.000791	CcSEcCtD
Granisetron—Dyspepsia—Epirubicin—testicular cancer	0.000347	0.00079	CcSEcCtD
Granisetron—Gastrointestinal pain—Methotrexate—testicular cancer	0.000345	0.000785	CcSEcCtD
Granisetron—Decreased appetite—Epirubicin—testicular cancer	0.000343	0.00078	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—testicular cancer	0.000341	0.000776	CcSEcCtD
Granisetron—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000341	0.000775	CcSEcCtD
Granisetron—Pain—Epirubicin—testicular cancer	0.000337	0.000768	CcSEcCtD
Granisetron—Constipation—Epirubicin—testicular cancer	0.000337	0.000768	CcSEcCtD
Granisetron—Urticaria—Methotrexate—testicular cancer	0.000335	0.000762	CcSEcCtD
Granisetron—Body temperature increased—Methotrexate—testicular cancer	0.000333	0.000758	CcSEcCtD
Granisetron—Abdominal pain—Methotrexate—testicular cancer	0.000333	0.000758	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000333	0.000757	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—testicular cancer	0.00033	0.000751	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—testicular cancer	0.000328	0.000746	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—testicular cancer	0.000325	0.000741	CcSEcCtD
Granisetron—Feeling abnormal—Epirubicin—testicular cancer	0.000325	0.00074	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—testicular cancer	0.000324	0.000739	CcSEcCtD
Granisetron—Gastrointestinal pain—Epirubicin—testicular cancer	0.000323	0.000734	CcSEcCtD
Granisetron—Dyspepsia—Doxorubicin—testicular cancer	0.000321	0.000731	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—testicular cancer	0.000317	0.000722	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000315	0.000717	CcSEcCtD
Granisetron—Urticaria—Epirubicin—testicular cancer	0.000313	0.000713	CcSEcCtD
Granisetron—Constipation—Doxorubicin—testicular cancer	0.000312	0.00071	CcSEcCtD
Granisetron—Pain—Doxorubicin—testicular cancer	0.000312	0.00071	CcSEcCtD
Granisetron—Body temperature increased—Epirubicin—testicular cancer	0.000312	0.00071	CcSEcCtD
Granisetron—Abdominal pain—Epirubicin—testicular cancer	0.000312	0.00071	CcSEcCtD
Granisetron—Hypersensitivity—Methotrexate—testicular cancer	0.000311	0.000707	CcSEcCtD
Granisetron—Asthenia—Methotrexate—testicular cancer	0.000302	0.000688	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—testicular cancer	0.000301	0.000685	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000298	0.000679	CcSEcCtD
Granisetron—Pruritus—Methotrexate—testicular cancer	0.000298	0.000679	CcSEcCtD
Granisetron—Hypersensitivity—Epirubicin—testicular cancer	0.000291	0.000661	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—testicular cancer	0.00029	0.00066	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—testicular cancer	0.000289	0.000657	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—testicular cancer	0.000289	0.000657	CcSEcCtD
Granisetron—Diarrhoea—Methotrexate—testicular cancer	0.000288	0.000656	CcSEcCtD
Granisetron—Asthenia—Epirubicin—testicular cancer	0.000283	0.000644	CcSEcCtD
Granisetron—Pruritus—Epirubicin—testicular cancer	0.000279	0.000635	CcSEcCtD
Granisetron—Dizziness—Methotrexate—testicular cancer	0.000279	0.000634	CcSEcCtD
Granisetron—Diarrhoea—Epirubicin—testicular cancer	0.00027	0.000614	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—testicular cancer	0.000269	0.000612	CcSEcCtD
Granisetron—Vomiting—Methotrexate—testicular cancer	0.000268	0.00061	CcSEcCtD
Granisetron—Rash—Methotrexate—testicular cancer	0.000266	0.000605	CcSEcCtD
Granisetron—Dermatitis—Methotrexate—testicular cancer	0.000266	0.000604	CcSEcCtD
Granisetron—Headache—Methotrexate—testicular cancer	0.000264	0.000601	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—testicular cancer	0.000262	0.000596	CcSEcCtD
Granisetron—Dizziness—Epirubicin—testicular cancer	0.000261	0.000594	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—testicular cancer	0.000258	0.000588	CcSEcCtD
Granisetron—Vomiting—Epirubicin—testicular cancer	0.000251	0.000571	CcSEcCtD
Granisetron—Nausea—Methotrexate—testicular cancer	0.00025	0.00057	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—testicular cancer	0.00025	0.000568	CcSEcCtD
Granisetron—Rash—Epirubicin—testicular cancer	0.000249	0.000566	CcSEcCtD
Granisetron—Dermatitis—Epirubicin—testicular cancer	0.000249	0.000566	CcSEcCtD
Granisetron—Headache—Epirubicin—testicular cancer	0.000247	0.000562	CcSEcCtD
Granisetron—Dizziness—Doxorubicin—testicular cancer	0.000241	0.000549	CcSEcCtD
Granisetron—Nausea—Epirubicin—testicular cancer	0.000234	0.000533	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—testicular cancer	0.000232	0.000528	CcSEcCtD
Granisetron—Rash—Doxorubicin—testicular cancer	0.00023	0.000524	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—testicular cancer	0.00023	0.000523	CcSEcCtD
Granisetron—Headache—Doxorubicin—testicular cancer	0.000229	0.00052	CcSEcCtD
Granisetron—Nausea—Doxorubicin—testicular cancer	0.000217	0.000493	CcSEcCtD
